The World Health Organization (WHO) has reiterated the natural origin of the novel coronavirus.
A senior official with the Chinese Ministry of Science and Technology, Wu Yuanbin, said on Sept 25 China has registered good results on the safety and efficiency of vaccines in the phase one and two clinical trials.
- NMPA Issued the Announcement on Issues Pertaining to the Current Administration on Drug Distribution
- NMPA and NHC Issued Regulations for Administration of Medical Device Extended Clinical Trials (Interim)
- NMPA Issued the Announcement on Issues Pertaining to the Implementation of the Newly Revised Provisions for the Supervision and Administration of Drug Production
- NMPA Issued 7 Guidances for Technical Review Including the Guidance for Technical Review of the Registration of Vertebroplasty Balloon Dilation Catheters
- Annual Report for National Medical Device Adverse Event Monitoring (2019) Released
- Annual Report for National Adverse Drug Reaction Monitoring (2019) Released